training increases phosphorylation of CaMKII in the hippocampus and rescues deficits in contextual memory formation of Tg2576 mice. 10 Bilateral infusion of CREB into dorsal hippocampus CA1 region of TgCRND8, one kind of the AD model mice, was sufficient to restore the hippocampal-dependent spatial memory of these animals.
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Magnesium cation (Mg 2+ ) is vital for many physiological processes.
Mental health depends on normal Mg
2+ intake, absorption, and metab- 13 MgT has also been shown to exert beneficial cognitive effects in genetically targeted mouse models of AD. 14, 15 Moreover, elevation of Mg 2+ in the hippocampus can enhance phosphorylation of CaMKII and CREB and activate their downstream pathways.
13
Although intensifies surrounding physical and social stimulation of the nervous system,environmental enrichment (EE) can improve physical and psychological well-being, refine physiological responses, and induce synaptic growth in laboratory animals. 16, 17 EE could increase expression of both presynaptic synaptophysin and postsynaptic PSD-95 in rodent brains. 18, 19 In the hippocampus of adult mouse, EE is also demonstrated to facilitate cell proliferation and neurogenesis of the dentate gyrus. 20 Moreover, studies using various behavioral tests have revealed EE-induced spatial memory improvement in mouse models of AD. [21] [22] [23] In the hippocampus and cortex of rat brains, EE stimulation can lead to increased levels of brain-derived neurotrophic factor (BDNF), which is an essential protein for central nervous system development and functions. 24, 25 Expression of NMDAR and the downstream signaling proteins, such as CaMKII, CREB, and ARC, are induced by EE. [26] [27] [28] There are no effective cures to AD currently. New insight and treatment strategies are in urgent need. Therefore, we sought to see whether combining EE with MgT, both of which have significant therapeutic effects on AD, would yield greater benefit than either used alone.
| MATERIALS AND METHODS

| Experimental animals
Transgenic heterozygous female mice (APPswe/PSEN1dE9) 29 and
wild-type (WT) female mice were obtained from the Model Animal ). This is consistent with the effective dose described previously. 14 For MgT-treated mice, drinking water was switched to MgT-containing water at 3 months of age (to evaluate long-term therapeutic effects) or 6 months of age (to evaluate short-term therapeutic effects) until the animals were killed. All mice were provided with standard food containing Mg
| MgT treatment
).
| Short-term environmental stimulus
As shown in the previous study, 14 for short-term environmental stimuli, 18-month-old mice were exposed to a relatively new context before being killed. Briefly, all animals were transferred to new EE cages (5-6 animals per cage) with new companion mice 24 hours before being killed. After 21 hours, toys and running wheels were placed in the cages. Three hours later, animals were killed. It is important to note that for each mouse raised under EE conditions, the cages and EE stimuli were novel, and the companion animals were introduced from other cages (either housed individually or housed under EE conditions in another cage).
| Novel object recognition test
The apparatus consisted of a square box (60 cm × 60 cm × 30 cm) made of polyvinyl chloride with white walls and floor. Mice were handled by the experimenter for 5 minutes once a day for 1 week.
One day before the experiment, each mouse received 2 sessions of habituation to the arena without any object (10 min/session). Four kinds of objects that were adopted for mice did not show natural preference among them. Each object has 4 identical copies. In the sample phase, mice were placed in the center of the box containing 2 identical objects. Each mouse was allowed to explore the box for 5 minutes and then returned to its home cage. After a short-term (1 hours) or long-term (24 hours) retention interval, the mouse was placed in the box for 5 minutes and exposed to a copy of former object in the sample phase and a novel object that the mouse had never seen before. During the trials, exploration of an object was defined as directing the nose to the object at a distance of less than 2 cm and/or touching it with the nose or forepaws. Data will not be adopted when a mouse spent less than 10 seconds on exploring objects in 1 test. Recognition ratio was calculated as a percentage ratio of time of each object over total time. The box and objects were cleaned with 20% ethanol between trials to avoid olfactory cues.
| Barnes maze task
The Barnes maze consisted of a white circular 
| Immunofluorescence
Synaptophysin immunoreactive presynaptic terminals density was quantified as described previously. were collected and merged into a single image. Therefore, the volume of brain tissue per image was ~78.6 × 78.6 × 1.8 × μm
3
. Three parallel sections of each mouse were performed scanning. The synapses number in the outer molecular layer of dentate gyrus (DG-OML) was estimated using Image-Pro Plus version 6.0 software (MediaCybernetics). Special filters to separate fluorescent puncta were applied and background levels were equalized.
| Western blotting analysis
Bilateral hippocampal tissues from 18-month-old mice which began 
| Statistics
Paired Student's t test was used to recognitive index of novel and familiar objects in NORT. Learning curves in the Barnes maze task were analyzed using two-way ANOVA followed by Dunnett's post hoc test for multiple comparisons. Unpaired Student's t test was used to analyze whether STE could enhance CaMKII and CREB phosphorylation ratio in each group. One-way ANOVA followed by LSD post hoc test for individual comparisons was used to analyze synaptophysin immunofluorescence result. P < 0.05 was considered statistically significant. All data were presented as mean ± SD.
| RESULT
| Long-term combination therapy with EE and MgT (EM) ameliorates memory deficit of AD mice
To investigate whether MgT could enhance effects of EE, APP/PS1 mice were exposed to EE (AE) or combination with EE and MgT (EM) treatment at 3 months of age. The NORT and Barnes maze were assessed at 15 and 17 months of age, respectively ( Figure 1A ).
In both short-term and long-term NORT, EM mice exhibited a significant preference for the novel object, and this preference was comparable to that of WT mice (paired t test P values: WT, P = 0.0008, EM, P = 0.0003 in 1-hours interval test; WT, P = 0.0405, EM, P = 0.0153 in 24-hours interval test, n = 9-10, novel vs familiar object; Figure 1B ,C).
In contrast, APP/PS1 transgenic mice (AD) did not spend more time exploring the new object in either short-or long-term NORT experiments (paired t test P values: P = 0.2327 in 1-hours interval test, P = 0.6224 in 24-hours interval test, n = 10, novel vs familiar object; Figure 1B , C). EE alone could rescue recognition memory in the shortterm NORT of AD mice, but it had no effect on the long-term paradigm (paired t test P values: P = 0.0012 in 1-hours interval test, P = 0.2496 in 24-hours interval test, n = 10, novel vs familiar object; Figure 1B ,C).
This result indicates that EM is more potent in ameliorating AD-related recognition memory impairment of AD mice.
Next, we tested the mice in the Barnes maze to investigate effects of the above treatments on spatial memory deficits. Overall, WT, AE, and EM mice found the hidden escape box faster than AD mice (treat- showed better spatial memory than the AE group. These results suggest that spatial memory impairment in AD mice could be restored by EM treatment and that the preventive effect is more efficient than EE treatment alone.
| Long-term combination therapy with EE and MgT (EM) prevents synaptic loss in AD mice
A main characteristic of AD is progressive synaptic transmission dysfunction that eventually leads to synaptic loss. 3 Thus, we investigated whether changes in synapse number were associated with different treatments. Synaptophysin is a presynaptic marker that is commonly used to determine the number of synapses. In DG region of AD mouse F I G U R E 1 MgT-enhanced therapeutic effects of EE in preventing memory impairment of AD mice. A, Schematic diagram of the experimental design. Four groups of mice were used: WT (n = 10), AD (n = 11), AE (n = 10), and EM (n = 9). EE and/or MgT treatment started at the age of 3 mos. B, Short-term (1 h) and C, long-term (24 h) NORT performed when the mice were 15 mos old. Recognition index was calculated as the percentage of time spent exploring each object. Black bars and gray bars indicate familiar and novel objects, respectively. Paired t tests analysis of percentage of time spent on novel and familiar object, * P < 0.05, ** P < 0.01, *** P < 0.001. Data are expressed as means ± SEM. D, Escape latencies during training in the Barnes maze performed on the same groups at 17 mos of age for 6 consecutive days. Two-way ANOVA analysis of effects of various treatments, F(3, 216) = 13.4, P < 0.0001. Multiple comparisons: * denotes significant differences between the EM and AD groups (*P < 0.05, **P < 0.01, ***P < 0.001), and # denotes significant differences between the WT and AD groups (#P < 0.05, ##P < 0.01). Data are expressed as means ± SEM hippocampi, synaptophysin-positive puncta were remarkably reduced.
EE treatment could completely prevent this loss, with puncta at normal levels (ANOVA effect of treatment, F(3, 16) = 11.74, P = 0.0003;
Multiple comparisons with AD: WT, P = 0.0057, AE, P = 0.01, EM, P = 0.0001). Interestingly, compared to WT or AE mice, EM mice have shown higher synaptic densities in the outer molecular layer of dentate gyrus (DG-OML), which indicates that MgT has an additive effect on synaptic restoration in AD mice when coupled with EE(compared with EM, WT, P = 0.0471, AE, P = 0.0279 Figure 2A , B).
| Short-term EE-MgT (EM) treatment reverses learning and memory deficits in AD mice
Having demonstrated that long-term (over 12 months) EM treatment which began at 3 months of age was the most effective therapy for AD model mice, we assessed the therapeutic effects of this combination after the onset of AD for a relatively short term (3 months) in another group of mice. In this experiment, AD mice received treatments at 6 months of age when memory deficits had already occurred as reported previously. 31 To clarify the effects of each treatment and their potential synergistic effects, in addition to the AD, WT, AE, and EM groups defined in the last experiment, we added a group of mice receiving MgT alone (AM) ( Figure 3A ). Figure 3B ). In contrast, mice from the AM, AE, and EM groups performed quite similar to WT mice in which they spent more time exploring the novel object (novel vs familiar object: WT, P = 0.008, n = 11; AM, P = 0.003, n = 14; AE, P = 0.024, n = 13; EM, P = 0.0012, n = 12; Figure 3B ). We then increased the difficulty of the test by extending the forgetting interval to 24 hours. As expected, the AM and AE mice did not show a preference for the novel object (novel vs familiar object: AD, P = 0.818, n = 16; AM, P = 0.318, n = 14; AE, P = 0.6675, n = 13; Figure 3C ), while the AEM mice still spent more time on the new object as WT mice did (novel vs familiar object: EM, P = 0.0037, n = 12; WT, P = 0.0294, n = 11 Figure 3C ).
In the Barnes maze test, our results showed that AM, AE, and compared to WT. Figure 3D ).
Thus, the combined treatment produced significant advantages over MgT or EE monotherapy to rescue cognitive memory and spatial memory in APP/PS1 mice, even when the treatment started when memory deficits had already occurred and a relatively shorter treatment period was used.
| The combination therapy (EM) activates the NMDAR pathway
Environmental enrichment and drug treatment can change the response of the central nervous system to external stimuli by adjusting protein expression levels and modifications. 32 The NMDAR signaling pathway has been shown to have a crucial role in cognition.
Environmental stimulation and MgT improved recognition of WT animals through activation of the NMDAR signaling pathway.
14 F I G U R E 2 EE-MgT (EM) prevented synaptic loss in the hippocampi of AD mice. Mice were sacrificed for immunofluorescence when they were 22 mos old. A, Representative fluorescence images of synaptophysin-positive puncta in the outer molecular layer of the dentate gyrus (DG). B, Quantitative analysis of synaptophysin puncta, WT, AD, AE, and EM, n = 5/group. One-way ANOVA analysis of effects of various treatments: F = 11.74, P = 0.003; Multiple comparisons: **P < 0.01, ***P < 0.0001, compared to AD; # P < 0.05, compared to EM. Data are expressed as means ± SEM. The scale bar represents 10 μm
To explore further the underlying mechanism of behavioral improvement achieved by EM treatment, we compared activities of key proteins in the NMDAR pathway. To this end, each group of mice was randomly divided into 2 subgroups at the age of 18 months ( Figure 3A) .
One subgroup was used to collect baseline phosphorylation levels, while the other subgroup was exposed to short-term environmental stimulation (STE) and then analyzed for phosphorylation levels.
14
In WT mice, STE significantly elevated phosphorylation levels of CREB, but it had no effect on CaMKII phosphorylation (baseline vs STE, CaMKII, P = 0.4286; CREB, P = 0.0173; Figure 4A ). Similar results
were obtained in the AM group (baseline vs STE, CaMKII, P = 0.556; CREB, P = 0.0159; Figure 4C ). In AD mice, STE did not enhance phosphorylation of either CaMKII or CREB (baseline vs STE, CaMKII, P = 0.5368; CREB, P = 0.7922; Figure 4B ). It is interesting that although EE could reverse memory impairment of AD mice, STE did not stimulate phosphorylation of either CaMKII or CREB (baseline vs STE, CaMKII, P = 0.329; CREB, P = 0.4286; Figure 4D ), which indicates that other pathways may be involved. It is noteworthy that phosphorylation levels of CREB and CaMKII in mice treated with EM were significantly increased by STE (baseline vs STE, CaMKII, P = 0.0079; CREB, 0.0079; Figure 4E ). The above results suggest that although both MgT and EE can partially improve recognition and memory of AD mice, the internal mechanism could be diverse. Nonetheless, synergetic effects of MgT and EE, especially in CaMKII activation, were observed in mice treated with both MgT and EE.
| DISCUSSION
Environmental enrichment has been demonstrated to slow memory loss associated with AD. 33 Human APP and PS1 transgenic mice are often studied as high-frequency mutations have been found in these F I G U R E 3 Short-term EE-MgT (EM) treatment reversed recognition and spatial memory impairment in AD mice. A, Schematic diagram of the experimental design. EE and/or MgT treatment started at 6 mos of age. Five groups of mice were used: WT (n = 11), AD (n = 16), AM (n = 14), AE (n = 13), and EM (n = 12). Behavioral testing was performed when the mice were 9 to 10 mos old. B, Short-term (1 h) NORT was performed when the mice were 9 mos old. C, Same as B, and from the same groups of mice but representing long-term (24 h) NORT performance. Black bars and gray bars indicate familiar and novel objects, respectively. Recognition index was calculated as percentage of time spent exploring each object. Paired t tests analysis of percentage of time spent on novel and familiar object, * P < 0.05, ** P < 0.01. D, Latency to find the hidden escape box during Barnes maze training trials. Two-way ANOVA analysis of the effects of various treatments, F(4, 366) = 18.14, P < 0.0001,* denotes significant differences between the WT and AD (*P < 0.05, **P < 0.01, ***P < 0.001), and # denotes significant differences between the EM and AD (#P < 0.05, ##P < 0.01). Data are expressed as means ± SEM Magnesium plays a critical role in the nervous system and the level was significantly lower in the brains of patients with AD than in age-matched controls. 37 It was found that elevating Mg 2+ levels in the brain can improve the memory of both young and aged rats. 54 or enhancing mitochondrial functions for better energy supply. 55 Therefore, more research is required to elucidate the precise mechanism underlying EE-dependent cognitive improvement.
In conclusion, the present study suggests that MgT can amplify therapeutic effects of EE treatment in preventing and reversing neuronal deficits in AD mice. In addition, compared with EE or MgT alone, EM can facilitate phosphorylation of CaMKII and CREB after STE.
Thus, our data suggest that combination of EE and MgT may be a novel therapeutic strategy for AD.
